Impairment of inhibitory control of the hypothalamic pituitary adrenocortical system in epilepsy

被引:80
作者
Zobel, A
Wellmer, J
Schulze-Rauschenbach, S
Pfeiffer, U
Schnell, S
Elger, C
Maier, W
机构
[1] Univ Klinikum Bonn, Klin & Poliklin Psychiat & Psychotherapie, D-53105 Bonn, Germany
[2] Univ Bonn, Dept Epileptol, D-5300 Bonn, Germany
关键词
epilepsy; depression; Dex/CRH test; HPA; cortisol; dexamethasone;
D O I
10.1007/s00406-004-0499-9
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Excess comorbidity between depression and epilepsy proposes common pathophysiological patterns in both disorders. Neuroendocrine abnormalities were often observed in depression as well as in epilepsy. Lack of inhibitory control of the hypothalamic pituitary adrenocortical (HPA) system is a core feature of depression; main relay stations of this system are located in the amygdala and hippocampus, which are key regions for both disorders. Therefore we explored the feedback mechanism of the HPA system in epilepsy. In order to control for the impact of depression we focused on epilepsies without depression. We compared patients with epilepsy (subdivided by medication with or without hepatic enzyme inducing antiepileptic medication) with 16 healthy controls and 16 patients with unipolar major depression but without epilepsy. We observed a lack of inhibitory control of the HPA system in patients with epilepsy, also in the absence of enzyme inducing medication. An impact of the temporal lobe location of the epileptic focus could not be observed. Thus, epilepsies share with depression the deficiencies in the feedback mechanism of the HPA system, proposing common pathophysiological features of up to now unknown nature.
引用
收藏
页码:303 / 311
页数:9
相关论文
共 80 条
[1]   Cellular pathology of amygdala neurons in human temporal lobe epilepsy [J].
Aliashkevich, AF ;
Yilmazer-Hanke, D ;
Van Roost, D ;
Mundhenk, B ;
Schramm, J ;
Blümcke, I .
ACTA NEUROPATHOLOGICA, 2003, 106 (02) :99-106
[2]   Temporal lobe epilepsy, temporal lobectomy, and major depression [J].
Altshuler, L ;
Rausch, R ;
Delrahim, S ;
Kay, J ;
Crandall, P .
JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 1999, 11 (04) :436-443
[3]   Novel mechanisms of action of three antiepileptic drugs, vigabatrin, tiagabine, and topiramate [J].
Ängehagen, M ;
Ben-Menachem, E ;
Rönnbäck, L ;
Hansson, E .
NEUROCHEMICAL RESEARCH, 2003, 28 (02) :333-340
[4]  
BARDELEBEN V, 1989, J NEUROENDOCRINOL, V1, P485
[5]   Reproductive dysfunction in women with epilepsy:: recommendations for evaluation and management [J].
Bauer, J ;
Isojärvi, JIT ;
Herzog, AG ;
Reuber, M ;
Polson, D ;
Tauboll, E ;
Genton, P ;
van der Ven, H ;
Roesing, B ;
Luef, GJ ;
Galimberti, CA ;
van Parys, J ;
Flügel, D ;
Bergmann, A ;
Elger, CE .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2002, 73 (02) :121-125
[6]   Enzyme induction and inhibition by new antiepileptic drugs: a review of human studies [J].
Benedetti, MS .
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2000, 14 (04) :301-319
[7]   Combined treatment with corticosteroids and moclobemide favors normalization of hypothalamo-pituitary-adrenal axis dysregulation in relapsing-remitting multiple sclerosis:: A randomized, double blind trial [J].
Bergh, FT ;
Kümpfel, T ;
Grasser, A ;
Rupprecht, R ;
Holsboer, F ;
Trenkwalder, C .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (04) :1610-1615
[8]   Autonomic, neuroendocrine, and immune responses to psychological stress: The reactivity hypothesis [J].
Cacioppo, JT ;
Berntson, GG ;
Malarkey, WB ;
Kiecolt-Glaser, JK ;
Sheridan, JF ;
Poehlmann, KM ;
Burleson, MH ;
Ernst, JM ;
Hawkley, LC ;
Glaser, R .
NEUROIMMUNOMODULATION: MOLECULAR ASPECTS, INTEGRATIVE SYSTEMS, AND CLINICAL ADVANCES, 1998, 840 :664-673
[9]  
Checkley S, 1996, BRIT MED BULL, V52, P597
[10]   THE CONCEPTS OF STRESS AND STRESS SYSTEM DISORDERS - OVERVIEW OF PHYSICAL AND BEHAVIORAL HOMEOSTASIS [J].
CHROUSOS, GP ;
GOLD, PW .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 267 (09) :1244-1252